Royalty Pharma plc RPRX
641 filings, 8 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 81 events
- Nov 4, 2026 Planned sale Terrance Coyne (Executive Vice President & Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 250,000 shares, runs to Feb 24, 2027
- Nov 4, 2026 Planned sale Marshall Urist, M.D., Ph.D. (Executive Vice President, Research & Investments) adopted a 10b5-1 trading planreported in the 10-Q, up to 150,000 shares, runs to Feb 2, 2027
- Nov 4, 2026 Planned sale Chris Hite (Executive Vice President & Chairman, Partnering & Investments) adopted a 10b5-1 trading planreported in the 10-Q, up to 323,200 shares, runs to Mar 12, 2027
- Nov 4, 2026 8-K Quarterly results8-K item 2.02
- Nov 4, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 5, 2026 Planned sale Urist Marshall (Officer) gave notice of a planned sale of 4,126 shares worth about $236KForm 144, approximate sale date Oct 5, 2026, under a 10b5-1 plan adopted Jun 26, 2026
- Sep 28, 2026 Planned sale Urist Marshall (Officer) gave notice of a planned sale of 4,126 shares worth about $239KForm 144, approximate sale date Sep 28, 2026, under a 10b5-1 plan adopted Jun 26, 2026
- Sep 22, 2026 Planned sale SCH Investment Partners LLC (Officer) gave notice of a planned sale of 100,000 shares worth about $5.8MForm 144, approximate sale date Sep 22, 2026, under a 10b5-1 plan adopted Mar 20, 2026
- Aug 18, 2026 Planned sale SCH Investment Partners LLC (Officer) gave notice of a planned sale of 100,000 shares worth about $6.0MForm 144, approximate sale date Aug 18, 2026, under a 10b5-1 plan adopted Mar 20, 2026
- Aug 13, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 11,002 shares worth about $644KForm 144, approximate sale date Aug 13, 2026, under a 10b5-1 plan adopted Feb 24, 2026
- Aug 12, 2026 Planned sale Errol B. De Souza (Former Affiliate) gave notice of a planned sale of 125,000 shares worth about $7.2MForm 144, approximate sale date Aug 12, 2026
- Aug 12, 2026 Planned sale Errol B. De Souza (Former Affiliate) gave notice of a planned sale of 206,352 shares worth about $11.9MForm 144, approximate sale date Aug 12, 2026
- Aug 5, 2026 Planned sale Marshall Urist, M.D., Ph.D. (Executive Vice President, Research & Investments) adopted a 10b5-1 trading planreported in the 10-Q, runs to Oct 9, 2026
- Aug 5, 2026 8-K Quarterly results8-K item 2.02
- Aug 5, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 1, 2026 Planned sale SCH Investment Partners LLC (Officer) gave notice of a planned sale of 100,000 shares worth about $5.7MForm 144, approximate sale date Jun 30, 2026, under a 10b5-1 plan adopted Mar 20, 2026
- Jul 1, 2026 Planned sale Urist Marshall (Officer) gave notice of a planned sale of 9,099 shares worth about $508KForm 144, approximate sale date Jul 1, 2026, under a 10b5-1 plan adopted Feb 12, 2026
- Jun 24, 2026 Planned sale Urist Marshall (Officer) gave notice of a planned sale of 9,098 shares worth about $502KForm 144, approximate sale date Jun 24, 2026, under a 10b5-1 plan adopted Feb 12, 2026
- Jun 23, 2026 Planned sale SCH Investment Partners LLC (Officer) gave notice of a planned sale of 150,000 shares worth about $8.2MForm 144, approximate sale date Jun 23, 2026, under a 10b5-1 plan adopted Mar 20, 2026
- Jun 23, 2026 Planned sale Christopher Hite (Officer) gave notice of a planned sale of 30,000 shares worth about $1.7MForm 144, approximate sale date Jun 23, 2026, under a 10b5-1 plan adopted Mar 20, 2026
- Jun 4, 2026 8-K Shareholder vote results8-K item 5.07
- May 28, 2026 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- May 26, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 64,399 shares worth about $3.5MForm 144, approximate sale date May 26, 2026, under a 10b5-1 plan adopted Feb 24, 2026
- May 20, 2026 Planned sale Urist Marshall (Officer) gave notice of a planned sale of 13,684 shares worth about $722KForm 144, approximate sale date May 20, 2026, under a 10b5-1 plan adopted Feb 12, 2026
- May 14, 2026 Planned sale Urist Marshall (Officer) gave notice of a planned sale of 13,684 shares worth about $726KForm 144, approximate sale date May 14, 2026, under a 10b5-1 plan adopted Feb 12, 2026
- May 14, 2026 Planned sale Norden Gregory (Officer) gave notice of a planned sale of 3,045 shares worth about $161KForm 144, approximate sale date May 14, 2026, under a 10b5-1 plan adopted Feb 12, 2026
- May 6, 2026 Planned sale Gregory Norden (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,614 shares, runs to Dec 31, 2026
- May 6, 2026 Planned sale Marshall Urist, M.D., Ph.D. (Executive Vice President, Research & Investments) adopted a 10b5-1 trading planreported in the 10-Q, up to 27,368 shares, runs to May 26, 2026
- May 6, 2026 Planned sale Terrance Coyne (Executive Vice President & Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 214,091 shares, runs to Aug 17, 2026
- May 6, 2026 Planned sale Christopher Hite (Executive Vice President & Chairman, Partnering & Investments) adopted a 10b5-1 trading planreported in the 10-Q, up to 630,000 shares, runs to Dec 10, 2026
- May 6, 2026 8-K Quarterly results8-K item 2.02
- May 6, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 28, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 34,791 shares worth about $1.7MForm 144, approximate sale date Apr 28, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Apr 13, 2026 8-K Regulation FD disclosure8-K item 7.01
- Apr 1, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 34,791 shares worth about $1.7MForm 144, approximate sale date Apr 1, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Mar 23, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 34,791 shares worth about $1.6MForm 144, approximate sale date Mar 23, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Mar 19, 2026 Planned sale George Lloyd (Officer) gave notice of a planned sale of 36,518 shares worth about $1.7MForm 144, approximate sale date Mar 19, 2026, under a 10b5-1 plan adopted Aug 20, 2025
- Mar 18, 2026 Planned sale George Lloyd (Officer) gave notice of a planned sale of 100,462 shares worth about $4.6MForm 144, approximate sale date Mar 18, 2026, under a 10b5-1 plan adopted Aug 20, 2025
- Mar 4, 2026 Planned sale George Lloyd (Officer) gave notice of a planned sale of 136,980 shares worth about $6.5MForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Aug 20, 2025
- Mar 2, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 34,791 shares worth about $1.7MForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Feb 23, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 34,791 shares worth about $1.6MForm 144, approximate sale date Feb 23, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Feb 11, 2026 8-K Quarterly results8-K item 2.02
- Feb 11, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 3, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 135,117 shares worth about $5.8MForm 144, approximate sale date Feb 3, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Feb 2, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 108,424 shares worth about $4.6MForm 144, approximate sale date Feb 2, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Jan 20, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 69,582 shares worth about $2.7MForm 144, approximate sale date Jan 20, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Jan 7, 2026 Planned sale George Lloyd (Officer) gave notice of a planned sale of 495,860 shares worth about $20.5MForm 144, approximate sale date Jan 7, 2026, under a 10b5-1 plan adopted Aug 20, 2025
- Jan 2, 2026 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 69,582 shares worth about $2.7MForm 144, approximate sale date Jan 2, 2026, under a 10b5-1 plan adopted Aug 8, 2025
- Dec 22, 2025 8-K Regulation FD disclosure8-K item 7.01
- Dec 22, 2025 8-K Director or officer change8-K item 5.02
- Dec 16, 2025 Planned sale Sandy Lamm LLC (Officer) gave notice of a planned sale of 160,000 shares worth about $6.1MForm 144, approximate sale date Dec 16, 2025, under a 10b5-1 plan adopted Sep 16, 2025
- Dec 15, 2025 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 69,582 shares worth about $2.7MForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted Aug 8, 2025
- Dec 1, 2025 Planned sale Sandy Lamm LLC (Officer) gave notice of a planned sale of 46,667 shares worth about $930KForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Aug 29, 2025
- Dec 1, 2025 Planned sale Urist Marshall (Officer) gave notice of a planned sale of 36,484 shares worth about $1.5MForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Aug 29, 2025
- Dec 1, 2025 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 69,582 shares worth about $2.8MForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Aug 8, 2025
- Nov 24, 2025 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 69,582 shares worth about $2.8MForm 144, approximate sale date Nov 24, 2025, under a 10b5-1 plan adopted Aug 8, 2025
- Nov 19, 2025 Planned sale George Lloyd (Officer) gave notice of a planned sale of 355,426 shares worth about $13.7MForm 144, approximate sale date Nov 19, 2025, under a 10b5-1 plan adopted Aug 20, 2025
- Nov 17, 2025 Planned sale Terrance Coyne (Officer) gave notice of a planned sale of 69,594 shares worth about $2.7MForm 144, approximate sale date Nov 17, 2025, under a 10b5-1 plan adopted Aug 8, 2025
- Nov 5, 2025 Planned sale Terrance Coyne (Executive Vice President & Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 835,000 shares, runs to Apr 30, 2026
- Nov 5, 2025 Planned sale George Lloyd (Executive Vice President, Investments & Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,125,246 shares, runs to Mar 20, 2026
- Nov 5, 2025 Planned sale Marshall Urist, M.D., Ph.D. (Executive Vice President, Research & Investments) adopted a 10b5-1 trading planreported in the 10-Q, up to 160,000 shares, runs to Jun 30, 2026
- Nov 5, 2025 8-K Quarterly results8-K item 2.02
- Nov 5, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Sep 16, 2025 8-K Material agreement signed, Other events8-K items 1.01, 8.01
- Aug 13, 2025 8-K Director or officer change8-K item 5.02
- Aug 6, 2025 8-K Quarterly results8-K item 2.02
- Aug 6, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 17, 2025 8-K Director or officer change8-K item 5.02
- May 19, 2025 8-K Material agreement signed, Acquisition or sale of assets completed, New debt or obligation, Director or officer change, Bylaws or fiscal year changed8-K items 1.01, 2.01, 2.03, 5.02, 5.03
- May 12, 2025 8-K Shareholder vote results8-K item 5.07
- May 8, 2025 8-K Quarterly results8-K item 2.02
- May 8, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 11, 2025 8-K Material agreement signed8-K item 1.01
- Apr 10, 2025 8-K Director or officer change8-K item 5.02
- Apr 9, 2025 SEC letter SEC asked 1 question about Form 10-K for the year ended December 31, 2024letters Mar 28, 2025 to Apr 9, 2025 · Results discussion (MD&A), Critical estimates
- Feb 12, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 11, 2025 8-K Quarterly results8-K item 2.02
- Jan 13, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jan 10, 2025 8-K Quarterly results8-K item 2.02
- Jan 10, 2025 8-K Material agreement signed, Unregistered share sale, Regulation FD disclosure8-K items 1.01, 3.02, 7.01
- Dec 31, 2024 8-K Material agreement signed, Bylaws or fiscal year changed8-K items 1.01, 5.03
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | 13F-NT | |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 6, 2026 | 4 | Insider trade |
| Nov 5, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 4, 2026 | 10-Q | Quarterly report |
| Nov 4, 2026 | 8-K | Quarterly results |
| Oct 5, 2026 | 144 | Notice of planned insider sale |
| Oct 5, 2026 | 4 | Insider trade |
| Sep 30, 2026 | 4 | Insider trade |
| Sep 30, 2026 | 4 | Insider trade |
| Sep 28, 2026 | 144 | Notice of planned insider sale |
| Sep 24, 2026 | 4 | Insider trade |
| Sep 22, 2026 | 144 | Notice of planned insider sale |
| Aug 19, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 144 | Notice of planned insider sale |
| Aug 17, 2026 | 4 | Insider trade |
| Aug 17, 2026 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Aug 14, 2026 | 13F-NT | |
| Aug 13, 2026 | 144 | Notice of planned insider sale |
| Aug 12, 2026 | 144 | Notice of planned insider sale |
| Aug 12, 2026 | 144 | Notice of planned insider sale |
| Aug 7, 2026 | 4 | Insider trade |
| Aug 7, 2026 | 4 | Insider trade |
| Aug 7, 2026 | 4 | Insider trade |
| Aug 7, 2026 | 4 | Insider trade |
| Aug 5, 2026 | 10-Q | Quarterly report |
| Aug 5, 2026 | 8-K | Quarterly results |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 1, 2026 | 144 | Notice of planned insider sale |
| Jul 1, 2026 | 144 | Notice of planned insider sale |
| Jun 30, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 4 | Insider trade |
| Jun 24, 2026 | 144 | Notice of planned insider sale |
| Jun 23, 2026 | 144 | Notice of planned insider sale |
| Jun 23, 2026 | 144 | Notice of planned insider sale |
| Jun 16, 2026 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| Jun 4, 2026 | 8-K | Shareholder vote results |
| May 28, 2026 | 4 | Insider trade |
| May 28, 2026 | 8-K | Material agreement signed, New debt or obligation |
| May 26, 2026 | 144 | Notice of planned insider sale |
| May 21, 2026 | 4 | Insider trade |
| May 20, 2026 | 144 | Notice of planned insider sale |
| May 15, 2026 | 4 | Insider trade |
| May 15, 2026 | 4 | Insider trade |
| May 14, 2026 | 144 | Notice of planned insider sale |
| May 14, 2026 | 144 | Notice of planned insider sale |
| May 14, 2026 | 13F-NT | |
| May 14, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 8, 2026 | 4 | Insider trade |
| May 8, 2026 | 4 | Insider trade |
| May 8, 2026 | 4 | Insider trade |
| May 8, 2026 | 4 | Insider trade |
| May 6, 2026 | 10-Q | Quarterly report |
| May 6, 2026 | 8-K | Quarterly results |
| Apr 30, 2026 | 4 | Insider trade |
| Apr 28, 2026 | 144 | Notice of planned insider sale |
| Apr 13, 2026 | 8-K | Regulation FD disclosure |
| Apr 10, 2026 | ARS | Annual report to shareholders |
| Apr 10, 2026 | DEFA14A | Extra proxy material |
| Apr 10, 2026 | DEF 14A | Proxy statement |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 1, 2026 | 144 | Notice of planned insider sale |
| Apr 1, 2026 | 13F-NT | |
| Mar 31, 2026 | 4 | Insider trade |
| Mar 25, 2026 | 4 | Insider trade |
| Mar 23, 2026 | 144 | Notice of planned insider sale |
| Mar 19, 2026 | 144 | Notice of planned insider sale |
| Mar 18, 2026 | 144 | Notice of planned insider sale |
| Mar 4, 2026 | 144 | Notice of planned insider sale |
| Mar 4, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Feb 25, 2026 | 4 | Insider trade |
| Feb 23, 2026 | 144 | Notice of planned insider sale |
| Feb 20, 2026 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 13, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 10-K | Annual report |
| Feb 11, 2026 | 8-K | Quarterly results |
| Feb 4, 2026 | 4 | Insider trade |
| Feb 3, 2026 | 144 | Notice of planned insider sale |
| Feb 2, 2026 | 144 | Notice of planned insider sale |
| Feb 2, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 144 | Notice of planned insider sale |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RPRX/export.csv") into a cell.